Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • Research Grant, 2016
    Characterization, Optimization and Validation of a Preformed Fibril Pre-clinical Model of Parkinson's Disease

    Study Rationale:
    New pre-clinical models have been developed to study the hypothesis that damaging forms of alpha-synuclein (protein involved in Parkinson's) spread across brain regions from a single...

  • Research Grant, 2016
    Design and Identification of a LRRK2 Kinase Structural Surrogate

    Study Rationale:

    Due to the importance of the LRRK2 protein in Parkinson's disease (PD), many academic and industrial laboratories have attempted to solve the three-dimensional structure of the kinase...

  • Access to Data and Biospecimens, 2016
    Evaluation of Glucocerebrosidase Pathway Biomarkers in Parkinson's Disease

    Study Rationale: 

    Parkinson disease (PD) due to monoallelic glucocerebrosidase (GBA1) gene mutations (GBA-PD) is at the forefront of novel approaches to the treatment of PD. Exciting potential...

  • Research Grant, 2016
    Electrical Stimulation of the Brain as Parkinson's Disease Treatment

    Study Rationale:
    Depression is a common non-motor symptom associated with Parkinson's disease (PD), and impulse control disorders (ICDs) are behaviors that may arise with use of certain PD medications...

  • Research Grant, 2016
    Registry for the Advancement of Deep Brain Stimulation Therapy in Parkinson's Disease (RAD-PD)

    Study Rationale:
    Deep brain stimulation (DBS) is a surgical treatment for Parkinson's disease (PD) that may benefit those who experience motor complications, such as "off" periods and/or dyskinesia...

  • Access to Data and Biospecimens, 2016
    MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’

    Study Rationale:

    MicroRNAs (miRNAs) are small regulatory RNAs controlling gene expression. We have recently reported reduced  miRNAs levels in serum from Parkinson disease (PD) patients, and also from...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.